Resmetirom

resmetirom · Madrigal Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for Resmetirom, covering 2023-09-05 to 2026-06-02. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 3 Study to Evaluate the Effect of Resmetirom on Clinical Outcomes in Patients With Well-compensated NASH Cirrhosis (MAESTRO-NASH-OUTCOMES) [Phase 3]

See pricing